1. |
Thurman JM, Renner B, Kunchithapautham K, et al. Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury[J]. J Biol Chem, 2009, 284:16939-16947.
|
2. |
Ramaglia V, Wolterman R, Kok M, et al. Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury[J]. Am J Pathol, 2008, 172:1043-1052.
|
3. |
Luo Y, Zhuo Y, Fukuhara M, et al. Effects of culture conditions on heterogeneity and the apical junctional complex of the ARPE-19 cell line[J]. Invest Ophthalmol Vis Sci, 2006, 47:3644-3655.
|
4. |
徐海峰, 王宜强, 王瑶, 等.曲安奈德对人视网膜色素上皮细胞活性与屏障功能的影响[J].中华眼底病杂志, 2005, 21:237-239.
|
5. |
Ablonczy Z, Crosson CE. VEGF modulation of retinal pigment epithelium resistance[J]. Exp Eye Res, 2007, 85:762-771.
|
6. |
Joseph K, Kulik L, Coughlin B, et al. Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner[J]. J Biol Chem, 2013, 288:12753-12765.
|
7. |
Robman L, Mahdi OS, Wang JJ, et al. Exposure to chlamydia pneumoniae infection and age-related macular degeneration: the Blue Mountains Eye Study[J]. Invest Ophthalmol Vis Sci, 2007, 48:4007-4011.
|
8. |
Kannan R, Zhang N, Sreekumar PG, et al. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells[J]. Mol Vis, 2006, 12:1649-1659.
|
9. |
Shirasawa M, Sonoda S, Terasaki H, et al. TNF-alpha disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium[J]. Exp Eye Res, 2013, 110:59-69.
|
10. |
Chen Y, Yang P, Li F, et al. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells[J/OL]. PloS one, 2011, 6:18139[2011-03-30]. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0018139.
|
11. |
Xie P, Kamei M, Suzuki M, et al. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344[J/OL]. PloS one, 2011, 6:28933[2011-12-19]. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0028933.
|
12. |
Bohana-Kashtan O, Ziporen L, Donin N, et al. Cell signals transduced by complement[J]. Mol Immunol, 2004, 41:583-597.
|
13. |
Chen YW, Yang CY, Jin NS, et al. Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization[J]. Eur J Immunol, 2007, 37:167-176.
|
14. |
Jin J, Zhou KK, Park K, et al. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor[J]. Invest Ophthalmol Vis Sci, 2011, 52:6230-6237.
|
15. |
Suzuki M, Tsujikawa M, Itabe H, et al. Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration[J].J Cell Sci, 2012, 125:2407-2415.
|
16. |
Liu J, Jha P, Lyzogubov VV, et al. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2(CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization[J]. J Biol Chem, 2011, 286:20991-21001.
|
17. |
Kunchithapautham K, Rohrer B. Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers[J]. J Biol Chem, 2011, 286:23717-23724.
|
18. |
Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization[J]. Proc Natl Acad Sci USA, 2006, 103:2328-2333.
|